---
title: "City-Scale Bioaerosol Response Through Federated Biological Digital Twins: An Architecture for Real-Time Threat Detection, Simulation, and Personalized Countermeasure Synthesis"
author: "Nicolas Waern"
email: ceo@winniio.io
keywords: bioaerosol defense, biological digital twin, federated learning, differential privacy, 3D bioprinting, city-scale simulation, personalized medicine, edge computing, SMILE methodology, biosecurity
status: draft
date: 2026-05-09
license: CC-BY-4.0
orcid: 0009-0001-4011-8201
---

# City-Scale Bioaerosol Response Through Federated Biological Digital Twins: An Architecture for Real-Time Threat Detection, Simulation, and Personalized Countermeasure Synthesis

**Nicolas Waern**
WINNIIO AB, Gothenburg, Sweden
ORCID: 0009-0001-4011-8201
ceo@winniio.io

*Working Paper — Draft for Open Review*
*License: CC-BY-4.0*
*Date: 2026-05-09*

---

## Abstract

Bioaerosol events — whether accidental industrial releases or deliberate attacks — represent one of the most asymmetric threats facing urban populations. Current response paradigms rely on population-level heuristics, retrospective epidemiology, and generalized pharmaceutical stockpiles. These approaches are structurally incapable of personalized, real-time response because they lack individual-resolution physiological ground truth. This paper proposes a federated architecture in which every citizen maintains a privacy-preserving biological digital twin (BDT), continuously updated from wearable, genomic, and clinical data streams, and synchronized — under strict differential privacy guarantees — with city-scale simulation infrastructure. When a bioaerosol event is detected by distributed environmental sensor networks, the architecture activates a four-phase response pipeline: (1) threat characterization via distributed aerosol modeling; (2) individualized vulnerability simulation across the federated BDT population; (3) personalized countermeasure synthesis using mechanistic pharmacological models; and (4) rapid fabrication via mobile biological 3D printing factories pre-positioned throughout the city. We argue this architecture could compress the effective response window from days or weeks to within 24 hours, transforming bioaerosol defense from a blunt public health instrument into a precision biosecurity capability. We ground the architecture in the SMILE methodology (Waern, 2026) and the Reality Construct framework (Waern, 2025), and we analyze it through Science and Technology Studies, systems engineering, information systems, and public health lenses. We articulate four falsifiable propositions, acknowledge significant technical and ethical limitations, and identify priority directions for future research.

**Keywords:** bioaerosol defense, biological digital twin, federated learning, differential privacy, 3D bioprinting, city-scale simulation, personalized medicine, edge computing, SMILE methodology, biosecurity

---

## 1. Introduction: The Asymmetry of Bioaerosol Threats

### 1.1 Attention: A Civilization-Scale Gap

Consider a scenario that is not science fiction but an engineering gap: a fine-particle aerosol — biological, chemical, or combined — disperses across a metropolitan area of two million people. Within three hours, the first symptomatic cases appear. Emergency systems activate population-level protocols developed in peacetime for a statistically average citizen. Some people recover without intervention. Others — elderly, immunocompromised, carriers of particular HLA variants, individuals with sub-clinical pulmonary conditions — begin a rapid deterioration cascade that generalized intervention cannot arrest.

The gap between what these protocols do and what biological reality demands is enormous. Current biodefense response systems know very little about the individual. They know the population. When the pathogen's lethality distribution is wide — that is, when the same exposure produces radically different outcomes depending on individual genotype, microbiome composition, metabolic state, and current immune activation — population-level response is not merely suboptimal. It is structurally inadequate.

This paper takes seriously a question that the architecture of modern cities has not yet confronted: what if every citizen had a biological digital twin — a continuously updated, privacy-preserving computational model of their physiology — and what if those twins could be activated collectively, in a federated manner, to simulate a threat, identify individual vulnerability profiles, and synthesize personalized countermeasures, all within a 24-hour window?

This is not a modest proposal. It sits at the intersection of at least five hard unsolved problems: federated machine learning at population scale, mechanistic biological simulation under time pressure, differential privacy for sensitive genomic and clinical data, real-time manufacturing orchestration, and governance of AI systems that make life-critical decisions. The ambition of the paper is not to solve all five but to show that they can be architecturally composed — that a federated biological digital twin network, combined with distributed manufacturing infrastructure, creates a system whose collective capability exceeds anything achievable by any of its components operating in isolation.

### 1.2 Interest: Why Now, and Why Digital Twins

The concept of a digital twin — a computational model that mirrors a physical entity and is updated in real time from sensor data — emerged in aerospace and manufacturing contexts (Grieves, 2014; Tao et al., 2018). Its migration into medicine and public health is accelerating. Topol (2019) argued that deep learning, combined with longitudinal patient data, is beginning to make individualized medicine computationally tractable. The Physiome Project (Hunter & Borg, 2003; Noble, 2002) has spent two decades building multi-scale computational models of human physiology. The P4 Medicine framework (Hood & Friend, 2011) articulated the vision of medicine that is Predictive, Preventive, Personalized, and Participatory — a vision that biological digital twins operationalize technically.

In parallel, the federated learning paradigm (McMahan et al., 2017) has demonstrated that machine learning models can be trained across distributed, privacy-preserving data silos without centralizing sensitive information. The formal privacy guarantees of differential privacy (Dwork et al., 2006; Dwork & Roth, 2014) provide a mathematical framework for quantifying and bounding privacy loss in such systems. Together, these two contributions — federated learning and differential privacy — dissolve what was, until recently, a genuine tension: the tension between the individual resolution needed for personalized medicine and the data centralization that machine learning typically requires.

The third enabling shift is in biological manufacturing. Advances in cell-free synthetic biology, inkjet-based bioprinting, and modular pharmaceutical fabrication platforms have begun to make point-of-need biological manufacturing credible (Murphy & Atala, 2014; Hinton et al., 2015). Mobile or semi-mobile fabrication units, analogous in concept to field hospitals but optimized for biological synthesis, represent an emerging capability class.

The convergence of these three currents — biological digital twins, federated privacy-preserving AI, and distributed biological manufacturing — creates a design space that has not yet been systematically explored in the biodefense literature. This paper maps that design space.

### 1.3 The Reality Construct as Grounding Framework

Before proceeding, it is necessary to articulate the epistemological foundation that governs the architecture proposed here. The Reality Construct (Waern, 2025) posits that computational systems gain trustworthiness in proportion to how faithfully they are grounded in empirically verifiable states of the physical world. In the context of biological digital twins, this means that a BDT is only as reliable as the real-world data streams that continuously update it. A twin that has not received a physiological signal update in 72 hours is increasingly fictional. A twin updated from continuous wearable data, periodic clinical laboratory values, and genomic baseline is increasingly real.

This is not a trivial distinction. In bioaerosol response, the difference between a model that reflects actual physiology and one that reflects a three-year-old clinical record could be the difference between a countermeasure recommendation that saves a life and one that induces a fatal adverse reaction. The Reality Construct framework demands that every component of the proposed architecture be assessed against its fidelity to real-world ground truth — and that fidelity gaps be explicitly surfaced to human decision-makers rather than papered over by model confidence scores.

The SMILE methodology (Waern, 2026) — Sovereign, Modular, Intelligent, Local-first, Explainable — provides the implementation framework. It constrains design choices at every layer: data sovereignty cannot be sacrificed for performance; components must be replaceable without cascading failures; AI outputs must be traceable to specific data inputs; processing must occur as close to the data source as physically possible; and every system output must carry a human-readable explanation of how it was derived.

---

## 2. Background and Related Work

### 2.1 Bioaerosol Threats: Scale and Heterogeneity of Response

Bioaerosol threats span a wide spectrum: natural events (wildfire smoke, fungal spore storms, viral fog conditions), industrial accidents (fermentation plant breaches, agricultural chemical drift), and deliberate release events (biological weapons, weaponized pathogens). The Sendai Framework for Disaster Risk Reduction (UNDRR, 2015) recognizes biological hazards as a priority risk category, though its operational guidance remains largely at the population and infrastructure level. WHO (2018) guidance on biological incident response emphasizes surveillance, laboratory confirmation, and communication, with limited attention to individualized physiological response modeling.

The epidemiological literature on bioaerosol response heterogeneity is extensive. Variants in ACE2 receptor expression modulate susceptibility to certain respiratory pathogens (Hoffmann et al., 2020). HLA allele distribution shapes cytokine storm risk profiles (Nguyen et al., 2020). Pre-existing microbiome composition influences innate immune response kinetics (Sencio et al., 2020). Metabolic state — insulin resistance, inflammatory baseline, oxidative stress load — determines the physiological reserve available for immune activation. The implication is clear: identical exposure events produce widely distributed outcome profiles, and a response system calibrated only to population means will systematically under-serve the tails of that distribution — precisely the individuals most likely to die.

### 2.2 Biological Digital Twins: State of the Art

The biological digital twin concept has been articulated at multiple scales. At the cellular level, systems biology approaches pioneered by Kitano (2002) and the SBML consortium (Hucka et al., 2003) have produced computational models of metabolic networks, signaling cascades, and gene regulatory systems. At the organ level, the Physiome Project (Hunter & Borg, 2003; Noble, 2002) has developed quantitative models of cardiac electrophysiology, respiratory mechanics, and renal function. At the whole-person level, integration remains the central challenge: multi-scale, multi-physics models that can plausibly simulate how a genomic variant affects a signaling pathway that affects organ function that affects systemic response to a pathogen remain computationally expensive and incomplete.

Collins and Varmus (2015) framed precision medicine as a program requiring both population-scale genomic data and individual-resolution phenotypic data — exactly the combination that a continuously updated biological digital twin provides. Topol (2019) documented the rapidly falling costs of the sensing modalities — continuous glucose monitoring, wearable heart rate variability, portable genomic sequencing — that make real-time BDT updating practically achievable.

In the industrial and urban digital twin literature (Grieves, 2014; Tao et al., 2018; Bauer et al., 2021), the federated twin concept — in which individual-level twins participate in population-level simulation while retaining local data sovereignty — has been proposed but not yet realized at city scale. The architecture described in this paper is, to the authors' knowledge, the first systematic specification of how a federated biological digital twin network would function as a bioaerosol response capability.

### 2.3 Federated Learning and Differential Privacy in Health Contexts

McMahan et al. (2017) introduced Federated Learning as a training paradigm in which a global model is learned from decentralized data without centralizing that data. Subsequent work demonstrated its applicability in medical imaging (Sheller et al., 2020), electronic health record analysis (Dayan et al., 2021), and genomic prediction (Warnat-Herresthal et al., 2021). The key insight is that model gradients — rather than raw data — are shared between nodes, and gradients can be protected with noise injection under differential privacy guarantees.

Dwork et al. (2006) formalized differential privacy as a mathematical guarantee: the output of a computation changes negligibly regardless of whether any individual's data is included or excluded. Dwork and Roth (2014) provided the comprehensive theoretical treatment. In the BDT context, differential privacy means that population-level simulation results — vulnerability maps, aggregate risk scores, optimal countermeasure distributions — can be derived from the federated twin network without exposing any individual's physiological profile.

The tension between privacy preservation and model utility is real and has been extensively studied. Abadi et al. (2016) demonstrated that deep learning with differential privacy is feasible with acceptable utility costs. The noise-accuracy tradeoff is governed by the privacy budget parameter epsilon — a design variable that the proposed architecture must expose to democratic governance rather than treat as a technical constant.

### 2.4 STS Perspectives: Sociotechnical Imaginaries and Boundary Objects

The architecture proposed in this paper is not only a technical system; it is a sociotechnical imaginary (Jasanoff & Kim, 2015) — a collectively held, institutionally stabilized vision of how technology and society should be co-constituted. The imaginary of real-time personalized biodefense is powerful precisely because it promises to dissolve a fundamental tension: the tension between collective security and individual sovereignty.

But sociotechnical imaginaries are not neutral. Jasanoff (2004) analyzed how different national regulatory cultures produce different imaginaries of acceptable biotechnology governance. The federated BDT architecture encodes specific assumptions: that citizens will consent to continuous physiological monitoring; that privacy-preserving computation is trustworthy; that automated countermeasure synthesis is safe enough to bypass traditional drug approval timelines in emergency conditions. Each assumption is contestable, and the legitimacy of the system depends on making those contestations explicit rather than burying them in software architecture.

Star and Griesemer (1989) introduced the concept of boundary objects — artifacts that are plastic enough to adapt to local needs yet robust enough to maintain a common identity across communities of practice. The biological digital twin, in this analysis, functions as a boundary object: it means something different to the epidemiologist (a population-scale epidemiological instrument), the clinician (a patient-specific decision support tool), the biosecurity analyst (a threat simulation engine), and the citizen (a personal health companion). Architectural choices that privilege one of these interpretations at the expense of others risk destroying the coalition of stakeholders needed to maintain and govern the system.

Callon's (1984) sociology of translation offers a further lens: the BDT network succeeds only if it successfully enrolls heterogeneous actors — citizens, clinicians, regulators, manufacturers, security agencies — into a shared problem formulation. The 24-hour response scenario is a powerful problematization: it frames the status quo as inadequate in a way that is hard to refute, and it proposes the federated BDT network as the obligatory passage point through which the solution must travel. But enrollment is never guaranteed. Actors re-translate the problem according to their own interests, and the sociology of this system will be as consequential as its engineering.

Beck's (1992) Risk Society framework adds a third STS dimension: bioaerosol threats are paradigmatic "manufactured risks" — hazards that emerge from the same industrial and technological systems that generate modernity's benefits. The proposed architecture is itself a manufactured system that introduces new risks (surveillance, algorithmic error, manufacturing failure) even as it addresses existing ones. A credible risk analysis must account for second-order risks, not merely first-order threats.

---

## 3. Architecture: The Federated Bioaerosol Response System

### 3.1 Overview and Design Principles

The proposed Federated Bioaerosol Response System (FBRS) is a four-layer architecture:

1. **Sensing Layer** — distributed environmental sensors, wearable personal sensors, clinical data streams
2. **Twin Layer** — individual biological digital twins, edge-resident, continuously updated
3. **Federation Layer** — privacy-preserving aggregation, population-level simulation, threat modeling
4. **Response Layer** — countermeasure synthesis, manufacturing orchestration, logistics coordination

The architecture is governed by five design principles derived from the SMILE methodology (Waern, 2026):

**Sovereign:** Every citizen's biological twin resides on infrastructure under that citizen's control — a personal device, a home edge node, or a trusted personal data store. No central entity has access to raw physiological data. Participation in federation is opt-in and revocable.

**Modular:** Each layer is replaceable without disrupting the others. The sensing layer can be upgraded from wearable to implantable sensors. The twin layer can evolve from statistical to mechanistic models. The federation layer can incorporate new privacy algorithms. The response layer can scale from pharmaceutical synthesis to cellular therapy. No component is irreplaceable.

**Intelligent:** AI operates at every layer, but its outputs are always traceable to specific data inputs. No black-box reasoning. Every vulnerability score, every countermeasure recommendation, every resource allocation decision carries a structured explanation referencing the data items from which it was derived.

**Local-first:** Processing occurs at the lowest possible layer. Individual twin simulation runs on personal edge hardware. Population-level aggregation runs on city-level edge infrastructure. Cloud compute is used only for tasks that genuinely require global context — novel pathogen characterization, cross-city epidemic modeling.

**Explainable:** Every output produced by the system must be interpretable by a non-specialist human decision-maker within 60 seconds. Automated actions cannot be taken without a human-readable rationale attached.

### 3.2 Sensing Layer: Environmental and Personal Data Acquisition

The sensing layer comprises three classes of sensors operating in parallel:

**Environmental aerosol sensors** are distributed throughout the city at a density calibrated to the prevailing wind patterns and population distribution. These sensors combine particle size analysis (to detect anomalous fine-particle concentrations indicative of biological aerosol), chemical signature detection (mass spectrometry and fluorescence-based bio-agent identification), and meteorological data (wind speed, direction, humidity, temperature) necessary for aerosol dispersion modeling. Real-time data from these sensors feeds a Computational Fluid Dynamics (CFD) model of the city's airspace, producing continuous estimates of bioaerosol concentration at every point in the urban environment.

**Personal wearable sensors** carried or worn by citizens provide continuous streams of physiological data: heart rate variability (HRV), blood oxygen saturation (SpO2), skin temperature, respiratory rate, electrodermal activity, and — in more advanced configurations — continuous glucose, continuous lactate, and environmental pathogen exposure metrics via personal air sampling cartridges. These streams update each citizen's biological digital twin in near-real time.

**Clinical data integration** connects the sensing layer to existing health information infrastructure: electronic health records, laboratory systems, pharmacy dispensing records, and emergency department intake data. Integration occurs through standardized interfaces (HL7 FHIR; see Mandl et al., 2020) with patient-controlled consent granularity, so that clinical data enriches the BDT only with explicit, ongoing authorization.

The integration of environmental sensing with personal physiological sensing is architecturally critical: it enables the system to compute not merely where the aerosol is, but which specific individuals — at their current physiological state — are being exposed, and with what estimated dose.

### 3.3 Twin Layer: The Biological Digital Twin

Each citizen's BDT is a multi-layer computational model residing on edge infrastructure under their control. The model integrates four representation levels:

**Genomic substrate:** A parsed and annotated representation of the individual's genome, focusing on pharmacogenomically relevant variants (CYP450 enzyme polymorphisms governing drug metabolism), immune-relevant HLA alleles, receptor expression variants, and pathogen susceptibility markers. This layer is static after initial sequencing unless updated by somatic mutation tracking.

**Physiological baseline:** A calibrated model of the individual's resting physiology — metabolic rate, inflammatory baseline (C-reactive protein, interleukin-6 trajectory), cardiac function parameters, pulmonary function, renal clearance, and hepatic metabolic capacity. This layer is updated from wearable and clinical data on a continuous to weekly basis.

**Dynamic state:** The continuously updated representation of the individual's current physiological state, derived from real-time wearable sensor streams. This includes sleep state, exertion level, current inflammatory activation, hydration and nutritional status, and medication levels. The dynamic state layer decays toward the baseline when sensor data is absent — a designed-in epistemic humility that surfaces data gaps rather than silently extrapolating.

**Pharmacological response model:** A mechanistic model — following Noble's (2002) physiome approach — that predicts how the individual will respond to specific pharmaceutical interventions given their genomic substrate, physiological baseline, and current dynamic state. This model is the core of the countermeasure synthesis pipeline.

The BDT is implemented as a set of composable, versioned computational modules. Each module carries a confidence score reflecting the recency and quality of the data that calibrated it. When a bioaerosol event is detected, the system computes a federated confidence score for the population as a whole, flagging individuals whose BDTs have insufficient data recency for reliable simulation — a transparency mechanism that supports, rather than replaces, human clinical judgment.

### 3.4 Federation Layer: Population-Scale Simulation Under Differential Privacy

The federation layer is the architectural heart of the FBRS. Its function is to aggregate information across millions of individual BDTs to produce population-level vulnerability maps, optimal resource pre-positioning recommendations, and prioritized countermeasure synthesis queues — without centralizing any individual's raw physiological data.

The mechanism is a variant of the federated learning paradigm (McMahan et al., 2017), adapted for biological simulation rather than machine learning. Each citizen's BDT node receives a "challenge query" — a parameterized representation of the detected bioaerosol agent — and runs a local simulation of how that individual's physiology would respond. The local simulation produces an outcome distribution: probability of severe illness, probability of fatal response, estimated time-to-critical-threshold, and optimal countermeasure class. These local outputs — not the raw physiological inputs — are then shared with the city-level aggregation layer.

Differential privacy (Dwork et al., 2006; Dwork & Roth, 2014) is enforced at the point of local output sharing. The local BDT node adds calibrated Gaussian noise to its output before transmission, with the noise magnitude set by a privacy budget parameter epsilon that is governed by a public, democratically accountable policy. The city-level aggregation layer combines noisy local outputs across the population using the Laplace mechanism and secure multi-party computation protocols, producing aggregate statistics whose accuracy scales with population size — exploiting the classical statistical property that noise averages out across many independent observations.

The key theoretical result that makes this architecture viable is the following: for a city of one million participating citizens, the aggregate vulnerability map derived from differentially private local outputs can achieve epidemiological accuracy comparable to a fully centralized, privacy-violating analysis, provided the privacy budget is set appropriately. This result follows from the composition theorems of differential privacy (Dwork & Roth, 2014) and the concentration inequalities that govern the accuracy of large-sample aggregations.

The federation layer also operates across spatial and temporal dimensions. Spatially, it maintains a continuous vulnerability surface: a grid of the city in which each cell contains an aggregate risk score, updated in real time as aerosol dispersion estimates are combined with local BDT simulation results. Temporally, it projects the vulnerability surface forward in time using the aerosol dispersion model and the BDT response kinetics, identifying which neighborhoods will cross critical risk thresholds in the next one, four, and twelve hours.

The governance of the privacy budget epsilon is explicitly not a technical decision. It is a policy decision that must be made by democratic institutions — city councils, public health authorities, civil liberties oversight bodies — with clear public understanding of the tradeoff: lower epsilon means stronger privacy protection and noisier aggregate estimates; higher epsilon means more accurate population-level analysis and weaker individual privacy guarantees. The architecture exposes this tradeoff transparently rather than resolving it silently.

### 3.5 Response Layer: Countermeasure Synthesis and Mobile Manufacturing

The response layer translates the population-level vulnerability map into concrete physical interventions: personalized countermeasures, synthesized in real time and delivered through pre-positioned manufacturing infrastructure.

**Countermeasure synthesis** operates at two levels. At the population level, the system identifies the countermeasure classes that, given the detected agent's properties and the population's aggregate pharmacogenomic profile, maximize expected lives saved across the vulnerability distribution. This is a stochastic optimization problem whose solution space is constrained by manufacturing capacity, material availability, and regulatory pre-authorization frameworks. At the individual level — for the highest-risk citizens identified by the vulnerability surface — the system generates personalized formulation recommendations that account for the individual's pharmacogenomic variant profile, current medication load, renal and hepatic clearance parameters, and body composition.

The mechanistic pharmacological models that enable individual-level formulation are not general-purpose: they are pre-computed for a library of countermeasure candidate molecules, pre-authorized under emergency biosecurity frameworks, and validated against the population's existing clinical data. This pre-authorization step is a governance prerequisite, not a technical afterthought. The list of pre-authorized countermeasure candidates must be established in peacetime, with full regulatory review, precisely because the time pressure of an actual bioaerosol event makes real-time regulatory deliberation impossible.

**Mobile biological 3D printing factories** are the physical instantiation of the response layer. The concept is analogous to pre-positioned field hospitals or mobile blood banks, but adapted for biological manufacturing. A mobile bioprinting factory is a containerized unit containing: (a) cell-free synthetic biology platforms capable of producing peptide-based therapeutics, monoclonal antibody fragments, and nucleic acid formulations; (b) sterile fill-finish equipment for producing injectable and inhalable dosage forms; (c) quality control instrumentation (mass spectrometry, HPLC) for in-process verification; and (d) cold chain and logistics management systems for distribution coordination.

The feasibility of mobile biological manufacturing is grounded in developments in cell-free protein synthesis (Pardee et al., 2016), portable DNA synthesis (Hughes & Ellington, 2017), and microfluidic pharmaceutical fabrication (Dong et al., 2020). Current limitations in throughput, yield, and quality consistency are real and are addressed in the Limitations section. The architecture does not assume that mobile bioprinting will replace industrial pharmaceutical manufacturing under normal conditions; it assumes only that a limited formulary of pre-authorized, design-validated countermeasures can be produced in sufficient quantity to address the highest-risk population segments within the 24-hour response window.

**Logistics orchestration** coordinates the distribution of synthesized countermeasures from manufacturing nodes to priority recipients. The optimization problem is a variant of vehicle routing with time windows, where priority weights are derived from the vulnerability surface and delivery urgency is a function of the individual's estimated time-to-critical-threshold. Drone delivery, autonomous vehicle networks, and pre-positioned community health workers are all considered as distribution modalities, with the selection governed by the city's existing infrastructure and regulatory environment.

### 3.6 The 24-Hour Timeline

The compressed timeline that makes this architecture transformative is worth examining explicitly. Consider the following idealized sequence:

**Hour 0-1: Detection and Characterization.** Environmental sensors detect anomalous bioaerosol concentrations. The CFD model computes initial dispersion estimates. Spectroscopic analysis produces a preliminary agent characterization — sufficient to select from the pre-authorized countermeasure library — within 30-45 minutes of detection.

**Hour 1-3: Federation Activation.** Challenge queries are transmitted to participating BDT nodes. Local simulations run in parallel across the city's edge infrastructure. Noisy local outputs are aggregated under differential privacy. The vulnerability surface reaches initial resolution — sufficient for triage-level resource pre-positioning — within two hours of federation activation.

**Hour 3-6: Manufacturing Initiation.** Mobile bioprinting factories at pre-positioned city nodes receive synthesis orders for the top-priority countermeasure formulations. Manufacturing begins. Highest-risk individual recommendations are routed to clinicians for human review and override.

**Hour 6-18: Manufacturing and Distribution.** Synthesis, quality verification, and packaging proceed. Logistics orchestration begins coordinating distribution networks. High-priority recipients — those whose BDTs indicate imminent critical deterioration — receive expedited delivery.

**Hour 18-24: Broad Distribution and Monitoring.** General-population countermeasures reach distribution points. BDT networks continue monitoring response kinetics, updating vulnerability estimates in real time, and flagging individuals who are not responding as predicted for escalated clinical intervention.

This timeline is ambitious. It is also conditional on a set of technical and governance prerequisites — pre-positioned manufacturing capacity, pre-authorized countermeasure libraries, fully updated BDT networks, functioning edge infrastructure — that represent years of peacetime investment. The 24-hour figure is a design target that constrains the architecture's requirements, not a claim about current capability.

---

## 4. Theoretical Analysis

### 4.1 Information Systems and Management Perspective

The FBRS can be analyzed as a distributed decision support system operating under extreme time pressure and radical uncertainty. From the Information Systems literature, several established frameworks apply.

The concept of organizational resilience (Weick & Sutcliffe, 2007) is relevant: the FBRS architecture embodies the principle of sensitivity to operations — maintaining a real-time picture of the current state of the system — and deference to expertise — routing decisions to the actors best positioned to make them, which in this case means routing individual countermeasure decisions through clinicians rather than executing them autonomously.

The SECI model of knowledge creation (Nonaka & Takeuchi, 1995) maps onto the BDT architecture in a non-trivial way: individual physiological knowledge (tacit, embodied) is externalized into the BDT model (explicit, computational), combined with population-level simulation results (explicit, aggregated), and internalized by clinicians and health authorities as actionable situational awareness. The federation layer is the combination phase of SECI operating at city scale.

Data governance frameworks (Wende & Otto, 2007) are directly applicable to the privacy budget governance challenge identified above. The epsilon parameter is a data governance object — a policy instrument that requires institutional ownership, democratic accountability, and regular review. Embedding it invisibly in software is a governance failure.

### 4.2 Engineering Perspective

From a systems engineering standpoint, the FBRS is a System of Systems (SoS) — a collection of independently operable systems that are integrated to produce emergent capabilities exceeding those of any component (Maier, 1998). SoS architectures introduce specific failure modes that single-system analyses miss: interface instability, emergent behaviors not predicted by component-level testing, cascade failures propagated through integration points.

Reliability engineering for the FBRS must account for correlated failure modes: a cyberattack that disrupts the federation layer simultaneously with a bioaerosol event is the adversarial scenario that the system's threat model must include. The SMILE principle of modularity — specifically, the requirement that each layer be independently operable — provides partial defense: if the federation layer is disrupted, individual BDTs can still provide component-level decision support to clinicians, even without population-level aggregation.

The computational requirements of the architecture are substantial. Running mechanistic physiological simulations for one million individuals simultaneously requires approximately 10^12 floating-point operations per simulation cycle, assuming a minimal mechanistic model per individual. Distributed across edge hardware — personal devices, smart city edge nodes, city data centers — this is feasible with current processor generations, but requires careful load balancing and graceful degradation when edge node availability is uneven.

### 4.3 Science and Technology Studies Perspective

Slovic's (1987) psychometric research on risk perception is relevant to the governance design of the FBRS. Citizens' willingness to participate in continuous physiological monitoring — and to share (even under privacy protection) their biological data for collective biodefense — will be shaped by perceptions of dread, novelty, and control that do not map straightforwardly onto technical privacy guarantees. A system that is mathematically privacy-preserving but experientially surveillance-like will fail to enroll the citizen participation on which its effectiveness depends.

Latour's (1987) analysis of how scientific facts are constructed through networks of allies applies to the pre-authorization process for countermeasure libraries. The determination of which molecules are safe enough to include in the pre-authorized library is not a purely technical judgment; it is a sociotechnical negotiation in which regulators, manufacturers, clinical researchers, patient advocates, and security agencies all participate. The outcome of this negotiation will shape the system's actual capability more than any architectural decision.

Jasanoff's (2004) comparative analysis of biotechnology governance in the United States, United Kingdom, and Germany revealed deep national differences in how regulatory cultures balance innovation against precaution. The FBRS architecture will be interpreted and governed differently in different national and municipal contexts, and a design that assumes a single governance model will fail in the majority of jurisdictions it encounters. The architecture must be governance-agnostic at the technical layer, providing hooks for different regulatory frameworks rather than embedding one.

### 4.4 Domain (Public Health and Biosecurity) Perspective

The Sendai Framework (UNDRR, 2015) prioritizes understanding disaster risk, strengthening disaster risk governance, investing in risk reduction, and enhancing preparedness for effective response. The FBRS architecture addresses all four priorities: it enhances understanding of biological risk through BDT vulnerability modeling; it creates new governance challenges that must be addressed institutionally; it requires significant peacetime investment; and it directly enhances response preparedness. Alignment with the Sendai Framework provides a legitimate policy basis for public investment in the architecture.

WHO's International Health Regulations (IHR, 2005) establish core capacity requirements for disease surveillance and response. The FBRS architecture is complementary to but not a replacement for IHR capacity — it operates at the municipal level and individual resolution, while IHR operates at the national level and population resolution. A city deploying the FBRS would need to establish clear protocols for information sharing with national public health authorities operating under IHR.

The One Health framework (WHO, 2017) recognizes the interconnection of human, animal, and environmental health. Bioaerosol threats frequently originate in zoonotic events or environmental contamination; a FBRS that incorporates environmental sensor data alongside human BDT data is inherently One Health-aligned. The architecture's sensing layer can be extended to include veterinary surveillance data and environmental microbiome monitoring without modifying the federation or response layers.

---

## 5. Falsifiable Propositions

The following propositions are specific enough to be tested empirically, and the proposed architecture stands or falls on them:

**Proposition 1 (Federated Simulation Accuracy):** A federated BDT network of N individuals, operating under differential privacy with privacy budget epsilon = 1.0, will produce population-level vulnerability maps whose sensitivity for identifying the top-10% highest-risk individuals exceeds 85%, compared to a privacy-violating centralized analysis, for N greater than 100,000.

*Test design:* Construct a simulated population of 500,000 synthetic individuals with known physiological parameters. Run both federated (with DP noise) and centralized vulnerability simulations for a library of test agents. Measure sensitivity and specificity of the federated system's top-10% identification against the centralized ground truth.

**Proposition 2 (Response Timeline Feasibility):** Under conditions of pre-positioned manufacturing capacity and pre-authorized countermeasure libraries, a mobile bioprinting network of 20 units serving a city of 500,000 can produce and initiate distribution of personalized countermeasures for the top-1% highest-risk individuals within 18 hours of bioaerosol detection.

*Test design:* Red team exercise with simulated detection event, real mobile manufacturing units, and logistics network modeling. Measure actual time from simulated detection to first countermeasure delivery at priority recipients.

**Proposition 3 (Privacy Budget Governance):** Democratic deliberation processes — structured public consultations combined with technical advisory panels — will converge on epsilon values in the range 0.1 to 1.0 for bioaerosol emergency scenarios, reflecting a meaningful privacy-accuracy tradeoff that can be operationalized in real deployments.

*Test design:* Multi-city deliberative process, structured as a citizens' assembly with technical expert input, with quantitative outcome measurement of preferred epsilon values and acceptable accuracy loss.

**Proposition 4 (Participation Threshold for Efficacy):** The FBRS achieves epidemiologically meaningful response improvement — reduction in severe illness rate of at least 20% compared to non-personalized response — only when BDT participation exceeds 40% of the city population, with BDT data recency within 30 days for at least 80% of participants.

*Test design:* Agent-based epidemic simulation with variable BDT participation rates and data recency distributions. Outcome measure: severe illness rate reduction compared to generalized-pharmaceutical baseline response.

---

## 6. Governance and Ethics

### 6.1 Sovereignty Architecture and Participation Design

The foundational governance principle of the FBRS is that citizen participation is voluntary, informed, revocable, and compensated. Voluntariness means that non-participation carries no civic penalty and no degradation of emergency services access. Informed means that the privacy implications of BDT participation — including the epsilon budget and its implications — are explained in accessible, verifiable terms before consent is sought. Revocable means that a citizen can withdraw their BDT from federation at any time, with cryptographic guarantees that their data is no longer included in aggregate computations. Compensated means that citizens who contribute their BDT data to collective biodefense receive tangible benefits — priority access to countermeasures, enhanced personal health intelligence, reduced insurance premiums — in exchange for their contribution.

The sovereignty principle extends to governance actors. Following the vision articulated in the grounding framework (Waern, 2025), every nation, every municipality, every organization, and every person maintains their own AI models, their own data, and their own context. The FBRS does not require any actor to surrender data sovereignty to participate in collective defense. The federation protocol is the mechanism by which sovereign agents contribute to collective intelligence without surrendering individual control.

### 6.2 Emergency Authorization and Human Oversight

A critical governance gap in the proposed architecture is the tension between response speed and human oversight. Automated countermeasure synthesis and distribution — even if technically feasible within the 24-hour window — cannot be legally or ethically executed without an established emergency authorization framework that clearly defines: (a) which decisions can be executed automatically, (b) which decisions require human review, (c) which decisions require institutional authorization, and (d) which decisions require democratic sanction.

The proposed framework is: automated execution is permissible only for decisions that are (1) within a pre-authorized decision envelope established in peacetime; (2) reversible within the response window; and (3) accompanied by a real-time human notification with override capability. Manufacturing initiation falls within this envelope for pre-authorized molecules. Individual countermeasure administration does not — it requires clinician review, even under emergency conditions, unless the individual has pre-authorized autonomous administration via their BDT consent framework.

### 6.3 Equity and Access

The FBRS introduces a new axis of health equity risk: citizens with more sophisticated BDTs — more frequent data updates, more complete genomic characterization, more capable edge hardware — will receive more accurate and more personalized countermeasure recommendations. Cities that deploy the FBRS must explicitly design for equity: providing BDT participation infrastructure to communities that cannot self-provision it, ensuring that the pre-authorized countermeasure library covers the pharmacogenomic diversity of the full population rather than only the majority genotypes, and monitoring countermeasure allocation in real time for equity metrics.

---

## 7. Limitations

The proposed architecture faces limitations that must be stated plainly rather than papered over.

**Biological model incompleteness.** Current mechanistic models of human physiology — even the most advanced Physiome Project implementations — are incomplete. Multi-scale coupling between genomic, cellular, organ, and systemic levels remains an active research frontier. For novel bioaerosol agents, the pharmacological response models that drive countermeasure synthesis will have been calibrated on existing data that may not capture the novel agent's mechanism of action. The system must surface model uncertainty explicitly rather than projecting false confidence.

**BDT update latency.** The effectiveness of the response pipeline depends on BDT data recency. In practice, not all citizens will have up-to-date BDTs: some will not have participated at all, some will have outdated wearable data, some will have genomic data but no recent clinical integration. The system must handle the partial-information case gracefully, using population-level priors for individuals with incomplete BDTs rather than excluding them from vulnerability assessment entirely.

**Manufacturing throughput.** Current mobile bioprinting platforms cannot produce pharmaceutical-grade biologics at the throughput required for city-scale response within 18-24 hours. The architecture assumes a future state of manufacturing capability that does not yet exist at the required scale, quality, or cost point. This is the single largest technical gap between the proposed architecture and current feasibility.

**Adversarial robustness.** The FBRS is a high-value target for adversarial disruption. A cyberattack that compromises the federation layer's differential privacy guarantees could deanonymize citizen physiological data. A supply chain attack that corrupts the pre-authorized countermeasure library could cause the system to synthesize and distribute harmful compounds. An adversary who understands the vulnerability surface could exploit it to maximize casualties in a second-wave attack timed to the detection threshold. The threat model must account for these adversarial scenarios, and the architecture must be tested against them.

**Regulatory pathway.** No regulatory framework currently exists for pre-authorizing mobile biological manufacturing of personalized countermeasures under emergency biosecurity conditions. Creating such a framework requires policy innovation across multiple jurisdictions and regulatory domains — pharmaceutical regulation, biosafety, emergency powers, data protection — that will take years to develop. The architecture cannot function without its governance prerequisites.

**Participation asymmetry.** Differential privacy guarantees degrade in small populations. In dense urban cores, participation may be sufficient for strong privacy guarantees. In lower-density neighborhoods, the same epsilon budget may provide weaker protection because the noise-to-signal ratio is less favorable. The architecture must account for spatial heterogeneity in participation density.

---

## 8. Future Research Directions

**Mechanistic BDT fidelity benchmarking:** Systematic evaluation of current physiome-level models against known pharmacological challenge data, identifying which biological systems are modeled with sufficient fidelity for emergency response use and which require further development. Priority systems include innate immune activation kinetics, pulmonary exposure-response models, and cytokine storm prediction.

**Federated simulation at scale:** Distributed computing implementations of federated BDT simulation at city scale, with empirical measurement of accuracy, latency, and computational cost as a function of population size, model complexity, and privacy budget.

**Mobile bioprinting formulary design:** Systematic evaluation of which countermeasure candidate molecules are suitable for mobile cell-free synthesis, with attention to yield, quality consistency, stability, and breadth of pharmacological coverage across the threat agent library.

**Governance experiments:** Structured deliberative processes — citizens' assemblies, multi-stakeholder workshops, regulatory sandboxes — to develop privacy budget governance frameworks, emergency authorization protocols, and equity monitoring mechanisms in specific municipal contexts.

**Edge hardware characterization:** Evaluation of current consumer and prosumer edge computing hardware for BDT simulation workload characteristics, identifying the minimum hardware specification required for reliable participation and the upgrade path for underserved communities.

**Adversarial robustness testing:** Red team exercises targeting the federation layer's privacy guarantees, the countermeasure library's integrity, and the logistics network's resilience, producing empirical characterizations of the attack surface and informing defense architecture.

**Cross-jurisdictional governance design:** Comparative policy analysis of how different national regulatory frameworks would need to be adapted to accommodate the FBRS architecture, identifying minimum necessary legal innovations and maximum feasible harmonization across jurisdictions.

---

## 9. Discussion: Toward a New Biosecurity Paradigm

The history of public health is, in part, a history of escalating information resolution. Miasma theory operated at the neighborhood level; germ theory at the pathogen level; epidemiology at the population level; precision medicine at the individual level. Each increase in resolution enabled a corresponding increase in intervention specificity. The biological digital twin network represents the next step in this trajectory: real-time, individual-resolution physiological ground truth applied to collective threat response.

What is genuinely novel in the architecture proposed here is not any single component — BDTs exist, federated learning exists, differential privacy exists, mobile bioprinting exists — but their composition into a response pipeline that operates within a 24-hour window. The 24-hour figure is not arbitrary: it is derived from what is known about the kinetics of many biological agents. Respiratory pathogens typically produce critical illness within 48-72 hours of high-dose exposure in vulnerable individuals. A response that identifies and treats the highest-risk individuals within 24 hours of aerosol detection can intervene before the critical deterioration window closes.

This is the sense in which the FBRS architecture represents a qualitative shift, not merely a quantitative improvement, over current response capabilities. Current systems can reduce mortality. The FBRS, at full capability, could make bioaerosol attacks against cities with full BDT coverage nearly non-lethal — transforming the strategic calculus for potential threat actors and potentially deterring attacks that are currently attractive precisely because of their asymmetric lethality.

This deterrence logic is powerful and potentially dangerous. If cities that deploy the FBRS are effectively immune to bioaerosol attacks, attacks may be redirected toward cities without coverage, toward rural populations, toward agricultural systems, or toward novel agent classes that fall outside the pre-authorized countermeasure library. The architecture changes the threat landscape; it does not eliminate it. This is a general property of defensive systems in adversarial environments, and it argues for thinking about the FBRS not as a city-level technology but as a global public health infrastructure project, analogous to vaccination programs that derive their power from coverage breadth.

The scale of the vision — every city, every person, every agent working together at the speed of latency — is not a marketing claim but an engineering requirement. A federated BDT network that covers 30% of a city's population provides 30% of the epidemiological insight that 100% coverage would provide, but it also introduces a systematic bias: the 70% not covered are not randomly distributed. They are disproportionately elderly, poor, technologically excluded, and — by many metrics — the most physiologically vulnerable. A partially deployed FBRS that protects the technologically enfranchised while leaving the vulnerable unmonitored and undertreated would be worse than no FBRS at all, because it would encode a structural health inequity in automated decision-making.

This is why the SMILE principle of sovereignty — edge-native, local-first, under individual control — is not merely a technical design choice but a health equity imperative. A centralized BDT architecture would inevitably concentrate infrastructure in areas with existing digital advantage. A distributed, edge-native architecture can be deployed incrementally, with public investment prioritized for underserved communities, because each node is independently operable.

The architecture described in this paper is a design, not a product. Its realization requires a coalition that does not yet exist: epidemiologists willing to validate BDT models against real exposure events; regulators willing to pre-authorize emergency countermeasure manufacturing protocols; manufacturers willing to invest in mobile bioprinting platforms before they have a proven demand; municipalities willing to invest in environmental sensor networks and edge infrastructure; and citizens willing to participate in continuous physiological monitoring in exchange for collective security benefits.

Building that coalition is a task for policy, not engineering. But it begins with articulating the vision with sufficient technical specificity that it can be seriously evaluated — celebrated where it is genuinely feasible, challenged where it is not, and refined where the challenges can be addressed by further research. That is what this paper attempts.

---

## 10. Conclusion

Bioaerosol threats expose a structural gap in current public health response: the gap between population-level intervention capability and individual-level physiological reality. Federated biological digital twins, governed by differential privacy and grounded in mechanistic physiological simulation, provide the technical foundation for closing that gap. Mobile biological manufacturing infrastructure provides the physical means of acting on individualized response recommendations within operationally relevant timeframes. The SMILE methodology and the Reality Construct framework provide the architectural principles that keep this system trustworthy, explainable, and sovereign at every layer.

The 24-hour response vision is ambitious. It requires technical advances in manufacturing throughput, biological simulation fidelity, and edge computing capacity that are real but achievable. More fundamentally, it requires governance innovation — pre-authorization frameworks, privacy budget governance, equity monitoring, emergency authorization protocols — that must be developed in peacetime and cannot be improvised under threat.

The four falsifiable propositions articulated in this paper provide a research agenda. The limitations section provides an honest accounting of what is not yet solved. The architecture provides a target for that research — a coherent vision of what the solved system would look like — without claiming that the solution already exists.

Cities are the organizing units of modern civilization. Bioaerosol threats are among the highest-consequence, lowest-warning-time risks those cities face. The question of whether federated biological digital twins can transform bioaerosol response from a blunt population instrument into a precision individual capability is one of the most consequential questions in applied biosecurity. This paper argues that the answer is yes — contingently, conditionally, and with a great deal of difficult work ahead.

---

## References

Abadi, M., Chu, A., Goodfellow, I., McMahan, H. B., Mironov, I., Talwar, K., & Zhang, L. (2016). Deep learning with differential privacy. *Proceedings of the 23rd ACM SIGSAC Conference on Computer and Communications Security*, 308–318. https://doi.org/10.1145/2976749.2978318

Bauer, P., Stevens, B., & Hazeleger, W. (2021). A digital twin of Earth for the green transition. *Nature Climate Change*, 11(2), 80–83. https://doi.org/10.1038/s41558-021-00986-y

Beck, U. (1992). *Risk society: Towards a new modernity*. Sage Publications.

Callon, M. (1984). Some elements of a sociology of translation: Domestication of the scallops and the fishermen of St. Brieuc Bay. *The Sociological Review*, 32(1_suppl), 196–233. https://doi.org/10.1111/j.1467-954X.1984.tb00113.x

Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. *New England Journal of Medicine*, 372(9), 793–795. https://doi.org/10.1056/NEJMp1500523

Dayan, I., Roth, H. R., Zhong, A., Harouni, A., Gentili, A., Abidin, A. Z., ... & Xu, D. (2021). Federated learning for predicting clinical outcomes in patients with COVID-19. *Nature Medicine*, 27(10), 1735–1743. https://doi.org/10.1038/s41591-021-01506-3

Dong, J., Burnham, J. A., Bhide, A., Gurav, G., & Bhattacharya, S. K. (2020). Microfluidic chip-based wearable and implantable biosensors for health monitoring. *Lab on a Chip*, 20(23), 4181–4200.

Dwork, C., McSherry, F., Nissim, K., & Smith, A. (2006). Calibrating noise to sensitivity in private data analysis. *Proceedings of the Third Theory of Cryptography Conference (TCC 2006)*, Lecture Notes in Computer Science, 3876, 265–284. https://doi.org/10.1007/11681878_14

Dwork, C., & Roth, A. (2014). The algorithmic foundations of differential privacy. *Foundations and Trends in Theoretical Computer Science*, 9(3–4), 211–407. https://doi.org/10.1561/0400000042

Grieves, M. (2014). Digital twin: Manufacturing excellence through virtual factory replication. *White Paper*, 1–7.

Hinton, T. J., Jallerat, Q., Palchesko, R. N., Park, J. H., Grodzicki, M. S., Shue, H.-J., ... & Feinberg, A. W. (2015). Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels. *Science Advances*, 1(9), e1500758. https://doi.org/10.1126/sciadv.1500758

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., ... & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. *Cell*, 181(2), 271–280. https://doi.org/10.1016/j.cell.2020.02.052

Hood, L., & Friend, S. H. (2011). Predictive, personalized, preventive, participatory (P4) cancer medicine. *Nature Reviews Clinical Oncology*, 8(3), 184–187. https://doi.org/10.1038/nrclinonc.2010.227

Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., ... & Wang, J. (2003). The systems biology markup language (SBML): A medium for representation and exchange of biochemical network models. *Bioinformatics*, 19(4), 524–531. https://doi.org/10.1093/bioinformatics/btg015

Hughes, R. A., & Ellington, A. D. (2017). Synthetic DNA synthesis and assembly: Putting the synthetic in synthetic biology. *Cold Spring Harbor Perspectives in Biology*, 9(1), a023812. https://doi.org/10.1101/cshperspect.a023812

Hunter, P. J., & Borg, T. K. (2003). Integration from proteins to organs: The Physiome Project. *Nature Reviews Molecular Cell Biology*, 4(3), 237–243. https://doi.org/10.1038/nrm1054

Jasanoff, S. (Ed.). (2004). *States of knowledge: The co-production of science and the social order*. Routledge.

Jasanoff, S., & Kim, S.-H. (Eds.). (2015). *Dreamscapes of modernity: Sociotechnical imaginaries and the fabrication of power*. University of Chicago Press.

Kitano, H. (2002). Systems biology: A brief overview. *Science*, 295(5560), 1662–1664. https://doi.org/10.1126/science.1069492

Latour, B. (1987). *Science in action: How to follow scientists and engineers through society*. Harvard University Press.

Maier, M. W. (1998). Architecting principles for systems-of-systems. *Systems Engineering*, 1(4), 267–284. https://doi.org/10.1002/(SICI)1520-6858(1998)1:4<267::AID-SYS3>3.0.CO;2-D

Mandl, K. D., Kohane, I. S., & Braunstein, M. (2020). SMART on FHIR: A standards-based, interoperable apps platform for electronic health records. *Journal of the American Medical Informatics Association*, 23(5), 899–908.

McMahan, H. B., Moore, E., Ramage, D., Hampson, S., & Aguera y Arcas, B. (2017). Communication-efficient learning of deep networks from decentralized data. *Proceedings of the 20th International Conference on Artificial Intelligence and Statistics (AISTATS)*, 54, 1273–1282.

Murphy, S. V., & Atala, A. (2014). 3D bioprinting of tissues and organs. *Nature Biotechnology*, 32(8), 773–785. https://doi.org/10.1038/nbt.2958

Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., & Thompson, R. F. (2020). Human leukocyte antigen susceptibility map for SARS-CoV-2. *Journal of Virology*, 94(13), e00510-20. https://doi.org/10.1128/JVI.00510-20

Noble, D. (2002). Modeling the heart — from genes to cells to the whole organ. *Science*, 295(5560), 1678–1682. https://doi.org/10.1126/science.1069881

Nonaka, I., & Takeuchi, H. (1995). *The knowledge-creating company: How Japanese companies create the dynamics of innovation*. Oxford University Press.

Pardee, K., Green, A. A., Takahashi, M. K., Braff, D., Lambert, G., Lee, J. W., ... & Collins, J. J. (2016). Rapid, low-cost detection of Zika virus using programmable biomolecular components. *Cell*, 165(5), 1255–1266. https://doi.org/10.1016/j.cell.2016.04.059

Sencio, V., Barthelemy, A., Tavares, L. P., Nascimento-Silva, M. C., Machado, M. G., Sime, M., ... & Trottein, F. (2020). Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. *Cell Reports*, 30(9), 2934–2947. https://doi.org/10.1016/j.celrep.2020.02.013

Sheller, M. J., Edwards, B., Reina, G. A., Martin, J., Pati, S., Kotrotsou, A., ... & Bakas, S. (2020). Federated learning in medicine: Facilitating multi-institutional collaborations without sharing patient data. *Scientific Reports*, 10(1), 12598. https://doi.org/10.1038/s41598-020-69250-1

Slovic, P. (1987). Perception of risk. *Science*, 236(4799), 280–285. https://doi.org/10.1126/science.3563507

Star, S. L., & Griesemer, J. R. (1989). Institutional ecology, "translations" and boundary objects: Amateurs and professionals in Berkeley's Museum of Vertebrate Zoology, 1907–39. *Social Studies of Science*, 19(3), 387–420. https://doi.org/10.1177/030631289019003001

Tao, F., Zhang, H., Liu, A., & Nee, A. Y. C. (2018). Digital twin in industry: State-of-the-art. *IEEE Transactions on Industrial Informatics*, 15(4), 2405–2415. https://doi.org/10.1109/TII.2018.2873186

Topol, E. J. (2019). *Deep medicine: How artificial intelligence can make healthcare human again*. Basic Books.

UNDRR. (2015). *Sendai Framework for Disaster Risk Reduction 2015–2030*. United Nations Office for Disaster Risk Reduction.

Waern, N. (2025). Reality Construct: A Framework for Grounding Digital Twin Systems in Verifiable Physical States. *Zenodo*. https://doi.org/10.5281/zenodo.19587944

Waern, N. (2026). SMILE Methodology: Sovereign, Modular, Intelligent, Local-first, Explainable Architecture for Edge-Native AI Systems. *WINNIIO AB Working Paper Series*.

Warnat-Herresthal, S., Schultze, H., Shastry, K. L., Manamohan, S., Mukherjee, S., Garg, V., ... & Schultze, J. L. (2021). Swarm learning for decentralized and confidential clinical machine learning. *Nature*, 594(7862), 265–270. https://doi.org/10.1038/s41586-021-03583-3

Weick, K. E., & Sutcliffe, K. M. (2007). *Managing the unexpected: Resilient performance in an age of uncertainty* (2nd ed.). Jossey-Bass.

Wende, K., & Otto, B. (2007). A methodological framework for data governance design. *Proceedings of the 13th Americas Conference on Information Systems (AMCIS 2007)*.

WHO. (2017). *One Health joint plan of action (2022–2026)*. World Health Organization.

WHO. (2018). *Guidance for managing ethical issues in infectious disease outbreaks*. World Health Organization.

---

*Working paper submitted for open review. Comments welcome at ceo@winniio.io.*
*License: Creative Commons Attribution 4.0 International (CC-BY-4.0)*
*All views expressed are those of the author in an independent research capacity.*
